Your session is about to expire
← Back to Search
MRI for Breast Cancer Diagnosis
N/A
Recruiting
Led By Bruce L Daniel
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Female with documented breast physical examination
Palpable or mammographically-detected suspect breast lesions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up length of one mri scan
Awards & highlights
Study Summary
This trial tests if MRI is a better way to diagnose breast cancer than existing methods.
Who is the study for?
This trial is for women with suspicious breast lesions, either felt by touch or seen in mammograms within the last 3 months. It's also open to those who've had a lumpectomy and now have new abnormalities. Men, pregnant or breastfeeding women, individuals with certain metal implants, severe claustrophobia, or allergies to MRI contrast agents cannot participate.Check my eligibility
What is being tested?
The study is testing how well magnetic resonance imaging (MRI) can identify and define breast cancer compared to established diagnostic methods like mammography.See study design
What are the potential side effects?
While MRIs don't typically cause side effects as they don't use radiation like X-rays do, some may experience discomfort from lying still during the scan or anxiety due to the enclosed space of the MRI machine.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman who has had a breast exam documented.
Select...
I have a lump in my breast or an abnormal mammogram.
Select...
I had a lumpectomy for breast cancer and now have suspicious changes needing a biopsy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ length of one mri scan
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~length of one mri scan
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Magnetic Resonance Imaging (MRI) of Breast CancerExperimental Treatment1 Intervention
Contrast-enhanced magnetic resonance imaging (MRI) using the standard department of Radiology MRI screening procedures. The duration of scanning may be variable, but will not exceed 90 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MRI
2009
Completed Phase 2
~1370
Find a Location
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,711 Previous Clinical Trials
7,509,442 Total Patients Enrolled
49 Trials studying Breast Cancer
110,340 Patients Enrolled for Breast Cancer
Stanford UniversityLead Sponsor
2,400 Previous Clinical Trials
17,341,384 Total Patients Enrolled
60 Trials studying Breast Cancer
110,735 Patients Enrolled for Breast Cancer
Bruce L DanielPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot have an MRI due to a pacemaker, metal in my body, severe fear of tight spaces, pregnancy, breastfeeding, or similar reasons.I am a woman who has had a breast exam documented.I've had an MRI with contrast or am allergic to MRI dye.I am biologically male.I have a lump in my breast or an abnormal mammogram.You need to have had a mammogram within the last 3 months before the MR studies.I had a lumpectomy for breast cancer and now have suspicious changes needing a biopsy.
Research Study Groups:
This trial has the following groups:- Group 1: Magnetic Resonance Imaging (MRI) of Breast Cancer
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger